SCHEMBL21224969

SCHEMBL21224969

O=C(O)N1CCCC2(CCCCNC2=O)C1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
OTUD7B Q6GQQ9 1/20 0.39
CRBN Q96SW2 5/20 0.36
DDB1 Q16531 1/20 0.33
GRIN1 Q05586 2/20 0.33
GRIN2A Q12879 2/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRM5 P41594 2/20 0.30
ACACB O00763 1/20 0.30
ACACA Q13085 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18132145 0.95 OTUD7B (0.40) OTUD7BCRBNDDB1GRIN1GRIN2A
SCHEMBL17611720 0.92 OTUD7B (0.46) OTUD7BCRBNDDB1GRIN1GRIN2A
SCHEMBL21224568 0.84 OTUD7B (0.37) OTUD7BCRBNDDB1GRIN1GRIN2A
SCHEMBL31580822 0.83 OTUD7B (0.36) OTUD7BCRBNDDB1GRIN1GRIN2A
SCHEMBL20395821 0.82 OTUD7B (0.53) OTUD7BCRBNDDB1
SCHEMBL18113471 0.82 OTUD7B (0.53) OTUD7BCRBNDDB1
SCHEMBL20395783 0.82 OTUD7B (0.53) OTUD7BCRBNDDB1
SCHEMBL22975109 0.79 USP30 (0.40) CRBNDDB1GRIN2BACACB
SCHEMBL2728185 0.79 OTUD7B (0.38) OTUD7BCRBNDDB1GRIN1GRIN2A
SCHEMBL19852842 0.78 OTUD7B (0.45) OTUD7BCYP1A2CYP3A4ACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024150815-A1 CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR 田辺三菱製薬株式会社 2024-07-18 WO disclosed
EP-3746442-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF Aptinyx Inc. (US) 2020-12-09 EP disclosed
WO-2019152678-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF APTINYX INC. (US) 2019-08-08 WO disclosed